首页|采用荧光偏振法建立HSP90抑制剂的高通量筛选模型

采用荧光偏振法建立HSP90抑制剂的高通量筛选模型

扫码查看
目的 建立HSP90抑制剂的高通量荧光偏振筛选模型.方法 以pET24α(+)-HSP90α转化E.Coli BL21(DE3),诱导表达并纯化HSP90α蛋白.Western blot鉴定纯化的HSP90α蛋白.以VER00051001为分子探针,依次变化HSP90α浓度和分子探针浓度,4℃孵育不同时间,检测荧光偏振值,建立HSP90α抑制剂的荧光偏振筛选模型.同时采用该模型检测格尔德霉素(Geldanamycin,CA)和NVP-AUY922对HSP90α的亲和抑制活性.结果 成功诱导表达并纯化HSP90α蛋白.选用80 nM分子探针,2.01μg/mL HSP90α蛋白建立荧光偏振筛选模型,其Z因子可达0.83.基于该方法,检测GA和NVP-AUY922对HSP90α的亲和抑制活性,其IC50值分别为55 nM和13 nM.结论 成功地建立了HSP90抑制剂的荧光偏振筛选模型.
Development of the high-throughput screening fluorescence polarization assay for HSP90 inhibitor
Objective To establish the high-throughput screening fluorescence polarization assay for HSP90 inhibitor.Methods E.coli strain BL21 ( DE3) competent cells were transformed with pET24α( +)-HSP90αplasmid.The cell lysate supernatant was induced to product the soluble protein and purified with Ni-NTA agarose.Western blot analysis was used to identify whether the purified protein is HSP90α.The fluorescence polarization assay for screening HSP90 inhibitors was established and optimized using varying concentrations of recombinant HSP90 protein and molecular probe VER00051001.Meanwhile, the binding activity of GA and NVP-AUY922 for HSP90αwas measured by fluorescence polarization assay.Results HSP90αwas induced expression and purified successfully.The fluorescence polarization assay was performed using 80 nM probe VER00051001 and 2.01μg/mL HSP90α, with the Z factor of 0.83.GA and NVP-AUY922 competed with the probes VER00051001 for binding sites of HSP90, with IC50 of 55 nM and 13 nM, respectively.Conclusion A reliable model was established using fluorescence polarization assay for screening HSP90 inhibitors.

fluorescence polarizationHSP90 inhibitorprotein expression and purification

薛妮娜、王春阳、杨瀚泽、陈越、金晶、陈晓光

展开 >

中国医学科学院药物研究所,药理室,天然药物活性物质与功能国家重点实验室/创新药物非临床药物代谢及PK/PD研究北京市重点实验室,北京 100050

荧光偏振 HSP90抑制剂 蛋白表达 纯化

国家自然科学基金面上项目

81573466

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(2)
  • 16